Clinical Trials on Alport Syndrome in Australia

Total 986 results

Genzyme, a Sanofi Company

Completed

ATHENA: Natural History of Disease Study in Alport Syndrome Patients (RG012-01)

Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2

France, Germany, Australia, United States, United Kingdom, Canada
Eloxx Pharmaceuticals, Inc.

Recruiting

A Study of ELX-02 in Patients With Alport Syndrome

Alport Syndrome

United Kingdom, Australia
The University of Queensland
Royal Brisbane and Women's Hospital

Unknown

Exercise in Critically Ill Patients With Sepsis

Sepsis Syndromes

Australia
Encoded Therapeutics

Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only)

Dravet Syndrome

Australia
Zydus Lifesciences Limited

Completed

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)

Cryopyrin Associated Periodic Syndrome

Australia
Inflazome UK Ltd

Completed

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334

Healthy Volunteers | Cryopyrin Associated Periodic Syndrome

Australia
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; Boehringer... and other collaborators

Completed

Can Resistance Enhance Selection of Treatment? (CREST)

HIV Infection

Australia
Peter MacCallum Cancer Centre, Australia
GlaxoSmithKline; Celgene Corporation

Completed

A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia (Aza-E)

Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)

Australia
The University of New South Wales

Completed

The Effect of Manuka Eye Drops on Tear Film Properties

Dry Eye Syndrome

Australia
The University of New South Wales

Completed

The Effect of Punctal Plugs on Tear Volume and Osmolality

Dry Eye Syndromes

Australia
Imago BioSciences, Inc., a subsidiary of Merck...

Completed

A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Australia
Genzyme, a Sanofi Company

Terminated

Study of Lademirsen (SAR339375) in Patients With Alport Syndrome (HERA)

Alport Syndrome

Australia, United States, China, France, Germany, Spain, United Kingdom
Deakin University

Completed

Efficacy of S-Adenosylmethionine in Fibromyalgia

Fibromyalgia Syndrome

Australia
The University of Western Australia

Unknown

High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome

Metabolic Syndrome X

Australia
Otsuka Australia Pharmaceutical Pty Ltd

Completed

Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire (TPMQ)

Myelodysplastic Syndrome (MDS)

Australia
AbbVie
Celgene; Genentech, Inc.

Completed

A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes (MDS)

United States, Australia, Germany
Medical University of Vienna
Croma-Pharma GmbH

Completed

Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses

Dry Eye Syndrome

Austria
Medical University of Vienna

Completed

Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye Syndrome

Dry Eye Syndromes

Austria
Medical University of Vienna

Completed

Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye Syndrome

Dry Eye Syndromes

Austria
Gerhard Garhofer
Croma-Pharma GmbH

Completed

Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation

Dry Eye Syndrome

Austria
Humanigen, Inc.

Suspended

Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)

Myelodysplastic Syndrome (MDS) | Myelofibrosis (MF)

United States, Australia
Medical University of Vienna

Terminated

Near Infrared Spectroscopy in Patients Undergoing Robotic Assisted Laparoscopic Surgery in the Trendelenburg Position

Nontraumatic Compartment Syndrome of Leg

Austria
Medical University of Vienna

Completed

Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome

Dry Eye Syndrome

Austria
Medical University of Vienna

Completed

Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy Subjects

Dry Eye Syndrome

Austria
Medical University of Vienna

Completed

Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome

Dry Eye Syndromes

Austria
Medical University of Vienna

Completed

Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome

Dry Eye Syndromes

Austria
Medical University of Vienna

Completed

Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome

Dry Eye Syndromes

Austria
Medical University of Vienna

Completed

Correlation of Different Signs for Assessment of Dry Eye Syndrome

Dry Eye Syndrome

Austria
AstraZeneca

Completed

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

Metabolic Syndrome | Dyslipidemia

Australia
Medical University of Vienna

Completed

Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy Subjects

Healthy | Dry Eye Syndrome

Austria
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)

France, Australia
University of Melbourne

Enrolling by invitation

Supporting the Recovery Needs of Patients Following Intensive Care

ICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care Syndrome

Australia
Medical University of Vienna

Withdrawn

Treatment of Dry Eye With Supplements

Dry Eye Syndromes

Austria
Michael Pfeilstöcker
Celgene Corporation

Completed

Analysis of Risk in MDS Over Time - Comparison of Treated vs Untreated Patients

Myelodysplastic Syndromes

Austria
Novartis

Completed

Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload

Myelodysplastic Syndromes | Hemoglobinopathies | Diamond-Blackfan Anemia | Transfusional Iron Overload | Other Inherited or Acquired Anaemia | MPD Syndrome | Other Rare Anaemias

Australia
AbbVie
Genentech, Inc.

Active, not recruiting

A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes (MDS)

United States, Australia, Canada, France, Germany, Italy, United Kingdom
Medical University Innsbruck
Institute of Mountain Emergency Medicine

Active, not recruiting

A 13-years Nationwide Study of Alpine Accidents in Austria

Climbing | Alpine Accident | Sleighing | Cycling | Canyoning | Hiking | Snowshoeing | Alpine Water-sport | Skiing/Snowboarding

Austria
The University of Western Australia
Sir Charles Gairdner Hospital; Perron Institute for Neurological and Translational...

Withdrawn

Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome

Tourette's Syndrome

Australia
Keogh Institute for Medical Research
Royal Perth Hospital

Completed

The Effects of Fish Oils on Blood Pressure, Heart Rate Variability and Liver Fat in the Polycystic Ovary Syndrome (fops)

Polycystic Ovary Syndrome

Australia
The University of Queensland
National Health and Medical Research Council, Australia

Completed

A Clinical Study in the Use of Orthotics in Treating Pain in the Front of the Knee

Patellofemoral Pain Syndrome

Australia
Medical University of Vienna

Recruiting

Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction

Dry Eye Syndromes | Meibomian Gland Dysfunction

Austria
Ascend Biopharmaceuticals Ltd

Completed

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Basal Cell Nevus Syndrome | Basal Cell Carcinoma

Australia
Medical University of Vienna

Completed

Local Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers

Dry Eye Syndromes

Austria
GCP-Service International West GmbH
Saint-Louis Hospital, Paris, France; Groupe Francophone des Myelodysplasies; Australasian... and other collaborators

Recruiting

Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy (IMpress)

Acute Myeloid Leukemia | Myelodysplastic Syndromes

Australia, France, Germany
Medical University of Vienna

Unknown

Surgical Treatment Of Complex Regional Pain Syndrome Type II (CRPS II)

CRPS Type II

Austria
Medical University of Vienna

Completed

Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers

Dry Eye Syndromes

Austria
Bayside Health

Unknown

Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions

Metabolic Syndrome X

Australia
Medical University Innsbruck
University Hospital, Bonn; Universitätsklinikum Leipzig

Recruiting

Sterile Inflammation and Molecular Aberrations in MDS (InflamGen)

Myelodysplastic Syndromes

Austria
Hospital Hietzing

Completed

Effect of Ciclosporin Eyedrops on Sjögren Syndrome

Dry Eye Syndromes

Austria
Race Oncology Ltd
Astex Pharmaceuticals, Inc.

Withdrawn

A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS (BISECT)

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic Syndrome

Australia

Clinical Trials on Alport Syndrome in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations